Top 10 Companies in India Hidradenitis Suppurativa Market | Insights & Key Players 2026

Top 10 Companies in India Hidradenitis Suppurativa Market

India hidradenitis suppurativa market is a specialized and growing segment within the country’s dermatology and healthcare sectors. Key players in the market are AbbVie India, Novartis Healthcare, Sun Pharmaceutical Industries, Johnson & Johnson, and Cipla Ltd.

India Hidradenitis Suppurativa Market Overview

According to 6Wresearch, the India hidradenitis suppurativa market is witnessing significant growth due to rising healthcare awareness, increasing diagnoses of the condition, and a growing demand for advanced treatment options. The market is also benefitting from the advancements in biologic treatments and targeted therapies that are improving the quality of life for HS patients.

Competitive Landscape

The competitive landscape in India hidradenitis suppurativa market is a mix of established global pharmaceutical companies and regional healthcare providers. These players are offering different treatment options including biologics, oral medications, and topical therapies, with a strong focus on research & development to provide effective and safe solutions.

Leading Players Operating in the India Hidradenitis Suppurativa Market:

1. AbbVie Therapeutics India Pvt. Ltd.

A global pioneer in the managed immunology segment, AbbVie provides sophisticated cloud-based solutions that handle complex compliance and large-scale workforce management for its gold-standard Humira (Adalimumab) therapy.

2. Novartis Healthcare Private Limited

A major force in the global space, Novartis focuses on multi-country compliance and AI-driven automation for large-scale multinational corporations through its innovative Secukinumab (Cosentyx) clinical programs.

3. Sun Pharmaceutical Industries Ltd.

A historic innovator in tech, Sun Pharma is renowned for being among the first to offer localized cloud computing solutions for biosimilar Adalimumab (Humimab) tailored for the Indian socioeconomic landscape.

4. Johnson & Johnson Pvt. Ltd.

A fast-growing unicorn in the premium segment that provides an end-to-end human capital management suite, integrating hardware with performance and talent management for its IL-12/23 inhibitor (Stelara) portfolio.

5. Cipla Ltd.

Caters to the modern workforce with an employee-centric platform that emphasizes transparency in processing and ease of use for administrative teams managing affordable chronic skin condition treatments.

6. Dr. Reddy's Laboratories Ltd.

A mobile-first platform that leverages biometric and geolocation data to provide high-precision attendance and system processing for exported biosimilars and complex generic skin therapies.

7. Biocon Limited

Leverages decades of global experience to provide technology-enabled system and benefits administration services tailored for high-volume biologic and biosimilar manufacturing in India.

8. Hetero Drugs Ltd.

Provides high-durability hardware processing and system management solutions, supporting some of the largest industrial frameworks in the country through its biosimilar production facilities.

9. Glenmark Pharmaceuticals Ltd.

A modern solution provider that integrates professional data science with data-driven hardware development to support northern and western India's digital-first dermatology and skin-care retail sectors.

10. Torrent Pharmaceuticals Ltd.

Leverages AI and mobile-first chemical science to automate high-precision therapeutic processing for the local urban ornamental and clinical dermatology markets.

Top 10 Companies in India Hidradenitis Suppurativa Market: FAQs